Xi Yan
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Antifungal resistance and susceptibility
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 6
-
- Angiogenesis and VEGF in Cancer 7
- Co-authors
- Feng Luo (8 shared papers)Ming Jiang (4 shared papers)Liqun Zou (2 shared papers)Yu Jiang (2 shared papers)Mei Li (1 shared paper)Yanyang Liu (3 shared papers)Xia Wang (3 shared papers)Zhixi Li (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Human Gene Therapy (2 papers)Annals of Oncology (2 papers)Oncology Reports (1 paper)Journal of Colloid and Interface Science (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xi Yan
29 papers receiving 369 citations
Xi Yan's Hit Papers
Peers
Comparison fields: 5 of 66
- Cancer Research 61
- Infectious Diseases 68
- Oncology 77
- Small Animals 22
- Epidemiology 65
Countries citing papers authored by Xi Yan
This map shows the geographic impact of Xi Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Yan more than expected).
Fields of papers citing papers by Xi Yan
This network shows the impact of papers produced by Xi Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Yan. The network helps show where Xi Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 81 | |
| 2 | 2015 | 31 | |
| 3 | 2019 | 29 | |
| 4 | 2024 | 26 | |
| 5 | 2022 | 22 | |
| 6 | Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial Hit paper breakdown → | 2025 | 22 |
| 7 | 2012 | 18 | |
| 8 | 2009 | 17 | |
| 9 | 2011 | 14 | |
| 10 | 2020 | 14 | |
| 11 | 2012 | 13 | |
| 12 | 2012 | 13 | |
| 13 | 2024 | 10 | |
| 14 | 2023 | 8 | |
| 15 | 2012 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2021 | 6 | |
| 18 | 2021 | 5 | |
| 19 | 2014 | 5 | |
| 20 | 2008 | 5 |
About Xi Yan
Xi Yan is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 35 papers that have together received 373 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (7 papers), Angiogenesis and VEGF in Cancer (7 papers), Cancer Treatment and Pharmacology (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Breast Cancer Treatment Studies (3 papers), Immune cells in cancer (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (61 citations), Infectious Diseases (68 citations), Oncology (77 citations), Small Animals (22 citations) and Epidemiology (65 citations). Xi Yan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Feng Luo, Ming Jiang, Liqun Zou, Yu Jiang, Mei Li, Yanyang Liu, Xia Wang, Zhixi Li, Qian Peng and Tao Ning. Their work appears in journals such as Journal of Clinical Oncology, Human Gene Therapy, Annals of Oncology, Oncology Reports and Journal of Colloid and Interface Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.